NCT02058212View on ClinicalTrials.gov

Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Endometriosis
Interventions
DRUG

ascorbate 1000mg, vitamin E 400, zinc and selenium

anti oxidant in the form of ascorbate 1000mg, vitamin E 400, zinc and selenium) are given to half patients only before IVF , plasma level of ROS are detected before and on day of oocyte retrieval then correlated to pregnancy outcome

Trial Locations (3)

1

Maadi

11451

egyption centre for IVF, Maadi

Maadi

All Listed Sponsors
lead

Cairo University

OTHER

NCT02058212 - Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI) | Biotech Hunter | Biotech Hunter